Aurora Cannabis ACB
NASDAQ ACB
$3.94 +0.13 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aurora Cannabis (ACB) Change in Account Payables (2021 - 2022)

Aurora Cannabis (ACB) posted quarterly Change in Account Payables of -$721968.9 for Q4 2022, down 125.8% year-over-year from $2.8 million in Q4 2021, and up 74.94% quarter-over-quarter from -$2.9 million in Q3 2022.

Aurora Cannabis (ACB) Change in Account Payables (2021 - 2022) Analysis & Trends

Aurora Cannabis (ACB) has reported Change in Account Payables for 2 consecutive years, with -$721968.9 the latest figure, recorded in Q4 2022.

  • In Q4 2022, Change in Account Payables fell 125.8% year-over-year to -$721968.9; the TTM figure through Dec 2022 stood at -$1.7 million (changed N/A YoY), while the FY2023 annual figure was $11835.1, changed N/A from the prior year.
  • Change in Account Payables climbed to -$721968.9 in Q4 2022 per ACB's latest filing, from -$2.9 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.8 million in Q4 2021 and bottomed at -$2.9 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Aurora Cannabis 243.01 Mn 170.70 Mn 25.75 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 -721,968.88
Dec 31, 2022 -721,968.88
Sep 30, 2022 -2.88 Mn
Sep 30, 2022 -2.88 Mn
Jun 30, 2022 -905,913.46
Jun 30, 2022 -905,913.46
Dec 31, 2021 2.80 Mn
Dec 31, 2021 2.80 Mn
Sep 30, 2021 -2.07 Mn
Sep 30, 2021 -2.07 Mn